Final guidance on prostate cancer screening recommends against offering testing to all men, multiple outlets report. Instead, the guidance says screening should be targeted to men who have a specific genetic variant and also have a relevant family history of certain cancers. The reporting indicates that experts advising on the guidance are focusing on identifying higher-risk individuals rather than applying screening universally. While the details of the criteria are described in terms of the genetic marker and family cancer history, the overall direction is consistent across sources: routine screening for the general male population is not recommended in this final version of the advice. The guidance therefore narrows eligibility to those considered more likely to benefit from screening based on the combination of hereditary risk factors, rather than age or broad screening programmes. The outlets do not describe additional policy changes beyond the recommendation to avoid testing all men and to limit screening to the specified risk group.